Avanos Medical, Inc. (AVNS)
 NYSE: AVNS · Real-Time Price · USD
 11.14
 -0.29 (-2.54%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Avanos Medical Revenue
Avanos Medical had revenue of $175.00M in the quarter ending June 30, 2025, with 1.92% growth. This brings the company's revenue in the last twelve months to $692.50M, up 1.48% year-over-year. In the year 2024, Avanos Medical had annual revenue of $687.80M with 2.15% growth.
Revenue (ttm) 
 $692.50M
Revenue Growth 
 +1.48%
P/S Ratio 
 0.74
Revenue / Employee 
 $310,956
Employees 
 2,227
Market Cap 
516.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 687.80M | 14.50M | 2.15% | 
| Dec 31, 2023 | 673.30M | -10.80M | -1.58% | 
| Dec 31, 2022 | 684.10M | 97.10M | 16.54% | 
| Dec 31, 2021 | 587.00M | -127.80M | -17.88% | 
| Dec 31, 2020 | 714.80M | 17.20M | 2.47% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 64.24B | 
| Eli Lilly and Company | 59.42B | 
| AbbVie | 58.33B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 56.37B | 
| Novo Nordisk | 49.11B | 
AVNS News
- 3 days ago - Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results - PRNewsWire
- 7 days ago - WRS Group Announces Agreement to Acquire Avanos Medical's US Game Ready® Orthopedic Rental Business - PRNewsWire
- 26 days ago - Avanos Medical: After Transformation Efforts, I Expect Inorganic Growth To Push The Price Up - Seeking Alpha
- 6 weeks ago - Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care - PRNewsWire
- 2 months ago - The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice - Seeking Alpha
- 3 months ago - Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors - PRNewsWire
- 3 months ago - Avanos Medical, Inc. Announces Second Quarter 2025 Results - PRNewsWire